<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02327819</url>
  </required_header>
  <id_info>
    <org_study_id>0440-14-TLV</org_study_id>
    <nct_id>NCT02327819</nct_id>
  </id_info>
  <brief_title>The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <brief_summary>
    <textblock>
      Supplementation of BCAA found to reduce the risk of developing liver cancer, but the affect
      of BCAA on existing liver cancer is unknown.

      The participants (post curative intent surgery) will be supplemented with either
      BCAA/non-BCAA-enriched protein supplement. The intervantion will go on for 2 years or until a
      new liver tumor is found.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2015</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>time until a new liver tumor is found</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Primary Liver Cancer</condition>
  <arm_group>
    <arm_group_label>BCAA supplement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Branched-chain amino acids supplement, 12 g/day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-BCAA protein supplement</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>non-BCAA protein supplement</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Branched-chain amoni acids (BCAA)</intervention_name>
    <arm_group_label>BCAA supplement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>non-BCAA protein supplement</intervention_name>
    <arm_group_label>non-BCAA protein supplement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosed primary liver cancer

          -  viral or Nonalcoholic Steatohepatitis Cirrhosis

          -  Cirrhosis rated Child-Pugh A

          -  liver cancer rated Barcelona Clinic Liver Cancer (BCLC) A

        Exclusion Criteria:

          -  Age (over 65)

          -  liver condition rated Child-Pugh B/C

          -  GI/Absorption issues

          -  patients given a treatment before surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clinical Nutrition Unit, Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 24, 2014</study_first_submitted>
  <study_first_submitted_qc>December 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2014</study_first_posted>
  <last_update_submitted>December 24, 2014</last_update_submitted>
  <last_update_submitted_qc>December 24, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 30, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

